Change Country
Welcome to Denmark
Please read the important information below before continuing to our website

By clicking on your client type to enter the website, you are confirming that you have read and understood the important information that is contained below, and you accept the terms of the Privacy and Cookies policy.


The UCITS ETFs listed on this website are funds under both Amundi ETF and Lyxor ETF denomination.

This website is published by Lyxor International Asset Management (LIAM), a French asset management company approved by the AMF (17 place de la Bourse 75082 Paris Cedex 02) under the UCITS (2009/65/EC) and AIFM (2011/31/EU) directives.

The website is hosted by on Microsoft Azure servers.

This website is subject to French and Danish law.


A professional client is a client that is either a per se professional client or an elective professional client (Note article 4 (1) 12 of Mifid )

Marketing Restrictions and Implications


Lyxor UCITS compliant Exchange Traded Funds (Lyxor UCITS ETFs) referred to on this website are open ended mutual investment funds (i) established under the French law and approved by the Autorité des Marchés Financiers (the French Financial Markets Authority), or (ii) established under the Luxembourg law and approved by the Commission de Surveillance du Secteur Financier (the Luxembourg Financial Supervisory Committee). Most of the protections provided by the Danish regulatory system generally and for funds authorised in Denmark do not apply to these exchange traded funds (ETFs).


This website is exclusively intended for persons who are not "US persons", as such term is defined in Regulation S or the US Securities Act 1933, as amended, and who are not physically present in the US. This website does not constitute an offer or an invitation to purchase any securities in the United States or in any other jurisdiction in which such offer or invitation is not authorised or to any person to whom it is unlawful to make such offer or solicitation. Potential users of this website are requested to inform themselves about and to observe any such restrictions.


Index Replication Process


Lyxor UCITS ETFs follow both physical and synthetic index replication process.


However, most Lyxor UCITS ETFs follow synthetic replication process. This consists of entering into a derivative transaction (a ‘Performance Swap’, as defined below) with a counterparty that provides complete and effective exposure to its benchmark index. Lyxor has adopted this methodology in order to minimise tracking error, optimise transaction costs and reduce operational risks.


A Performance Swap is a contractual agreement which is negotiated over-the-counter (OTC) between two parties: the Lyxor UCITS ETF and its counterparty. From a risk perspective, each Performance Swap ranks equally with other senior unsecured obligations of the counterparty, such as common bonds (i.e., same rights to payments). In the Performance Swap, the counterparty of the Lyxor UCITS ETF commits to pay the Lyxor UCITS ETF a variable return based on a pre-determined benchmark index, instead of a fixed stream of income (as in bonds). At the same time, the counterparty will receive from the Lyxor UCITS ETF the performance and any related revenues generated by the basket's assets (excluding the value of the Performance Swap) held by the Lyxor UCITS ETF. Information provided on individual ETFs includes data on the basket relating to the ETF and the percentage value of the basket represented by each asset. The information is relevant to the closing values on the date given. 


Investment Risks


The Lyxor UCITS ETFs described on this website are not suitable for everyone. Investors' capital is at risk. Investors should not deal in this product unless they understand, having obtained independent professional advice where necessary, its nature, terms and conditions, and the extent of their exposure to risk. The value of the product can go down as well as up and can be subject to volatility due to factors such as price changes in the underlying instrument and interest rates. If a fund is quoted in a different currency to the index, currency risks exist.


Prior to any investment in any Lyxor UCITS ETF, you should make your own appraisal of the risks from a financial, legal and tax perspective, without relying exclusively on the information provided by us. We recommend that you consult your own independent professional advisors (including legal, tax, financial or accounting advisors, as appropriate).


Specific Risks


·         Capital at Risk. ETFs are tracking instruments: Their risk profile is similar to a direct investment in the Benchmark Index. Investors’ capital is fully at risk and investors may not get back the amount originally invested. Investments are not covered by the provisions of the Financial Services Compensation Scheme (“FSCS”), or any similar scheme.

·         Counterparty Risk. Investors may be exposed to risks resulting from the use of an OTC Swap with any counterparty. Physical ETFs may have Counterparty Risk resulting from the use of a Securities Lending Programme.

·         Currency Risk. ETFs may be exposed to currency risk if the ETF or Benchmark Index holdings are denominated in a currency different to that of the Benchmark Index they are tracking. This means that exchange rate fluctuations could have a negative or positive effect on returns.

·         Replication Risk. ETFs are designed to replicate the performance of the Benchmark Index. Unexpected events relating to the constituents of the Benchmark Index may impact the Index provider’s ability to calculate the Benchmark Index, which may affect the ETF’s ability to replicate the Benchmark Index efficiently. This may create Tracking Error in the ETF.

·         Underlying Risk. The Benchmark Index of a Lyxor ETF may be complex and volatile. When investing in commodities, the Benchmark Index is calculated with reference to commodity futures contracts which can expose investors to risks related to the cost of carry and transportation. ETFs exposed to Emerging Markets carry a greater risk of potential loss than investment in Developed Markets as they are exposed to a wide range of unpredictable Emerging Market risks.

·         Liquidity Risk. On-exchange liquidity may be limited as a result of a suspension in the underlying market represented by the Benchmark Index tracked by the ETF; a failure in the systems of one of the relevant stock exchanges, Market Maker systems; or an abnormal trading situation or event.


The securities can be neither offered in nor transferred to the United States.




Any statement in relation to tax, where made, is generic and non-exhaustive and is based on our understanding of the laws and practice in force as of the date of this document and is subject to any changes in law and practice and the interpretation and application thereof, which changes could be made with retroactive effect. Any such statement must not be construed as tax advice and must not be relied upon. The tax treatment of investments will, inter alia, depend on an individual’s circumstances. Investors must consult with an appropriate professional tax adviser to ascertain for themselves the taxation consequences of acquiring, holding and/or disposing of any investments mentioned on this website. 

Further information on the risk factors are available in the Risk Warning section of the website.


Any fund prospectus and supplements are available at Information given about the past performance of the funds is no guarantee of future performance. No investment decision should be taken without reading the fund prospectus and any fund supplement of the fund concerned.


Although the content of the website is based upon information that LIAM consider reliable or comes from sources that LIAM consider reliable, LIAM have not verified such information. Lyxor make no representation or warranty as to the accuracy, completeness or adequacy of any information.  Any reproduction, disclosure or dissemination of the materials available on the website is prohibited.



This website uses cookies to make the website work or improve your user experience. Cookies are small text files that are saved on your computer or device, which are used for several purposes such as detecting preferences and improving site navigation. By continuing to use this website you consent for cookies to be used. For more details, including how to amend your preferences, please read our Cookies Policy.

By clicking on your client type to enter the website, you shall be deemed to have represented to us that you are not a U.S. person and that you are not located in the United States of America, its territories and possessions, and any State of the United States of America and that you are authorised to receive the information to and on this website.

August, 2015




We have a new home

Banner Amundi

Read more
18 Jan 2019

What’s going to move markets in 2019

Unbelievably, yet another year has flown by. And what an eventful year it’s been – quite possibly one of the toughest for financial markets in half a century. There’s a lot to look forward to (or worry about) in 2019 so we wanted to share our Cross Asset Research team’s views on their five biggest themes including the future for Europe, the emerging markets and the ageing US cycle, before party season really kicks in. That’s it from us for this year. Thanks for reading and all the best for 2019.

1 – Europe’s differences will deepen

European assets are pricing in very little economic growth, but sentiment could easily reverse should political risks recede. Eurozone equities have been trading at around 12.2 x 12-months forward PE - 15% below their 30-yr average and around 25% lower than US valuations.  Until now though, the catalysts have been catatonic.

However, progress towards an orderly Brexit, a resolution to the rupture with Rome, an easing of trade tensions and signs of a recovery in growth could spur a re-rating. You may need to act fast - potential rate hikes in Q3 could sap the rally’s energy and push the cost of debt and the EUR higher.

We favour stability at this stage, so we’re calling the CAC over the DAX (“gilets jaunes” nothwithstanding) although the latter could be in demand should trade tensions fade. Switzerland, once again, may offer a bit of haven.  Periphery country balance sheets look weak and more exposed to any softening of growth. Certainty on the Brexit outcome can’t be a bad thing, but sterling will bounce, to the detriment of exporters.

We’ll be shifting our sector allocations into late-cycle corporates gradually, especially those capable of delivering robust earnings during cyclical slowdowns – which tend to be found in Healthcare, Oil & Gas, Financials and Basic Industries.

As for bonds? We’ll be watching out for a possible change in the Italian government’s stance and a potentially sharp narrowing of BTP-bund spreads. Holding peripheral debt could still make sense, provided you can hold your nerve.  Euro bonds will be vulnerable prior to any policy tightening, but the ECB is likely to err on the side of caution and deliver just one, minimal (10bps) hike by September 2019. Oil price recovery and firmer economic momentum should push inflation expectations higher.  

2 – EM equities should enjoy some respite

After a largely lacklustre 2018, sentiment on the emerging markets should improve in 2019. Trade, as ever, remains the talking point. Any easing of tension – something G20 leaders at least nodded to in Buenos Aires in late November - could support any equity rebound. Don’t, however, wait too long. Tighter liquidity conditions will weigh on returns in the longer term.  

Some selectivity won’t go amiss. Take China - escalating trade tensions, a weaker yuan and deleveraging have all weighed heavily on stocks in recent months. A crackdown on shadow banking – a crucial source of funding for the private sector – also looms large. GDP growth should slow to around 6% over the next 12 months.

Seen differently though, that sell-off is quite possibly excessive given domestic consumption is 62% of growth. And that growth is twice as fast as the US (the world’s largest economy) and three times faster than the rest of the developed world. And the Chinese government retains plenty of ammunition to underpin growth in 2019. The upside potential is huge, provided the Chinese model shifts toward sustainable growth – which assumes firmer consumption, higher capex and greater financial access.

Elsewhere, a lesser dependence on exports and improving domestic conditions, have insulated India from the ongoing trade conflicts. Earnings growth is also back above long-term averages and some profit normalisation is expected for financials. The next five years could be well about growth and corporate re-leveraging, a dual push that may help improve company return on equity ratios and ultimately, share price performance. 

3 –  The end of the US cycle is approaching, but no imminent threat of recession

The US economy finally looks set to slow in 2019 after a buoyant year in 2018. President Trump’s fiscal stimulus has probably done enough to avert the threat of recession until early 2021, but cyclical concerns are likely to become a major market driver in H2. GDP growth may already be on a downward trend by then.

Tight labour, rising wage costs and the difficulty of passing these costs on to consumers should narrow margins and disincentivise investment and hiring. There’s limited potential for capital gains in a world of stretched valuations and tighter liquidity conditions.

US small caps would clearly be hindered by gridlock on the Hill. They would also suffer should the dollar weaken or the cost of debt rise. We expect broad, larger-cap indices to be more resilient. Growth stocks could struggle however given new tax regimes and regulations. 

Indices like the S&P 500 should stay strong in the first part of the year but with the end of the cycle hoving into view, higher downside pressure is inevitable in H2. Risk reducers may well provide some comfort.

4 – H1 will be the time to hedge against higher rates and inflation

We expect to feel the pressures of higher inflation in H1. Trade tariffs, high capacity utilisation rates, and higher labour cost pressures in developed markets will fuel the fire, as will some form of recovery in oil prices. Higher tariffs may push inflation expectations higher right through to the summer. Ultimately, inflation breakevens have room to price more uncertainty in inflation via higher term premia, particularly coming from any spill-over into the setting of domestic prices. Inflation-linked assets should outperform nominal bonds, at least over the first half of the year.

Downside risks are more prevalent in H2 however.  Inflation expectations would be vulnerable to a worsening of financial conditions (notably wider credit spreads and weaker equities), especially in an environment of slowing growth. As late cycle assets, commodities can act as a hedge against higher inflation and downside pressures on the USD. 

5 – Global equities will face more volatility, and more downside pressure

The upside in global equities looks limited overall. Most financial assets’ valuations are stretched with the exception of Treasuries, inflation markets and some emerging market assets. Meanwhile, a more concerted central bank push towards monetary policy normalisation will also put a cap on global liquidity just when debt has never been higher. Fiscal policy uncertainty will linger, but may become less stressful once there is clarity from Europe. In the US, the likelihood of another fiscal boost looks much lower now that Trump’s hands have been tied.

We’ll be keeping an eye on growth rates, and trying to exploit and react to the different speeds on display. After several stimulus-fuelled years of plenty, we expect US economic activity to slow in the second part of the year but a modest easing of growth also looks possible Europe with Italy on the verge of recession. The expensive US dollar will eventually weaken against other major currencies should the Fed bring its tightening cycle to an end.  

As a result, we expect US assets to become more volatile as we progress through the year, most obviously in H2. Euro area equities should benefit from a combination of economic relief and better visibility on Italy’s policymaking, but any concern about growth and corporate earnings  may cap upside potential. Risk reducers may prove useful, while value may prove to be the best equity hedge against rising rates.

Risk Warning​

This document is for the exclusive use of investors acting on their own account and categorised either as “Eligible Counterparties” or “Professional Clients” within the meaning of Markets in Financial Instruments Directive 2014/65/EU. These products comply with the UCITS Directive (2009/65/EC). Société Générale and Lyxor International Asset Management (LIAM) recommend that investors read carefully the “investment risks” section of the product’s documentation (prospectus and KIID). The prospectus and KIID are available free of charge on, and upon request to

The products mentioned are the object of market-making contracts, the purpose of which is to ensure the liquidity of the products on the London Stock Exchange, assuming normal market conditions and normally functioning computer systems. Units of a specific UCITS ETF managed by an asset manager and purchased on the secondary market cannot usually be sold directly back to the asset manager itself. Investors must buy and sell units on a secondary market with the assistance of an intermediary (e.g. a stockbroker) and may incur fees for doing so. In addition, investors may pay more than the current net asset value when buying units and may receive less than the current net asset value when selling them. Updated composition of the product’s investment portfolio is available on In addition, the indicative net asset value is published on the Reuters and Bloomberg pages of the product, and might also be mentioned on the websites of the stock exchanges where the product is listed.

Prior to investing in the product, investors should seek independent financial, tax, accounting and legal advice. It is each investor’s responsibility to ascertain that it is authorised to subscribe, or invest into this product. This document is of a commercial nature and not of a regulatory nature. This material is of a commercial nature and not a regulatory nature. This document does not constitute an offer, or an invitation to make an offer, from Société Générale, Lyxor Asset Management (together with its affiliates, Lyxor AM) or any of their respective subsidiaries to purchase or sell the product referred to herein.

Lyxor International Asset Management (LIAM), société par actions simplifiée having its registered office at Tours Société Générale, 17 cours Valmy, 92800 Puteaux (France), 418 862 215 RCS Nanterre, is authorized and regulated by the Autorité des Marchés Financiers (AMF) under the UCITS Directive (2009/65/EU) and the AIFM Directive (2011/31/EU). LIAM is represented in the UK by Lyxor Asset Management UK LLP, which is authorized and regulated by the Financial Conduct Authority in the UK under Registration Number 435658. Société Générale is a French credit institution (bank) authorised by the Autorité de contrôle prudentiel et de résolution (the French Prudential Control Authority).

Research disclaimer

Lyxor International Asset Management (“LIAM”) or its employees may have or maintain business relationships with companies covered in its research reports. As a result, investors should be aware that LIAM and its employees may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Please see appendix at the end of this report for the analyst(s) certification(s), important disclosures and disclaimers. Alternatively, visit our global research disclosure website

Conflicts of interest 

This research contains the views, opinions and recommendations of Lyxor International Asset Management (“LIAM”) Cross Asset and ETF research analysts and/or strategists. To the extent that this research contains trade ideas based on macro views of economic market conditions or relative value, it may differ from the fundamental Cross Asset and ETF Research opinions and recommendations contained in Cross Asset and ETF Research sector or company research reports and from the views and opinions of other departments of LIAM and its affiliates. Lyxor Cross Asset and ETF research analysts and/or strategists routinely consult with LIAM sales and portfolio management personnel regarding market information including, but not limited to, pricing, spread levels and trading activity of ETFs tracking equity, fixed income and commodity indices. Trading desks may trade, or have traded, as principal on the basis of the research analyst(s) views and reports. Lyxor has mandatory research policies and procedures that are reasonably designed to (i) ensure that purported facts in research reports are based on reliable information and (ii) to prevent improper selective or tiered dissemination of research reports. In addition, research analysts receive compensation based, in part, on the quality and accuracy of their analysis, client feedback, competitive factors and LIAM’s total revenues including revenues from management fees and investment advisory fees and distribution fees.

Connect with us on linkedin